Skip to content
Triangle logo TriangleGet started
← Full study record

NCT05061095 · OUTCOME

Preliminary Efficiency of Best-Worst Scaling (BWS) Survey

Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey · Source last updated 2024-12-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Up to 7 days after treatment decision

What was measured

Number of patients who respond moderately effective/very affective to "how effective was the survey to help you and your doctor choose a treatment that was consistent with your goals?"

Analysis population: Participants with newly-diagnosed hematologic malignancies who completed survey.

Groups in this outcome

Pilot Testing:

Participants with newly-diagnosed hematologic malignancies who participated in the questionnaire portion of the study.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Pilot Testing:19

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pilot Testing:9Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        9
denoms
  1. counts
    1. group Id
      OG000
      value
      19
    units
    Participants
description
Number of patients who respond moderately effective/very affective to "how effective was the survey to help you and your doctor choose a treatment that was consistent with your goals?"
groups
  1. description
    Participants with newly-diagnosed hematologic malignancies who participated in the questionnaire portion of the study.
    id
    OG000
    title
    Pilot Testing:
param Type
COUNT_OF_PARTICIPANTS
population Description
Participants with newly-diagnosed hematologic malignancies who completed survey.
reporting Status
POSTED
time Frame
Up to 7 days after treatment decision
title
Preliminary Efficiency of Best-Worst Scaling (BWS) Survey
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice